Genetics and Sensorineural Pathophysiology

Group leaders

Miguel Ángel Moreno Pelayo

Matías Morín Rodríguez

mmorenop(ELIMINAR)@salud.madrid.org

Principal Investigator

  • Francisco Javier del Castillo Fernández del Pino
  • Ignacio del Castillo Fernández del Pino

Collaborating Staff

  • Yolanda Martín Santo Domingo
  • Ana María Valero Rubio
  • Manuela Villamar López
  • Verónica Barca Tierno
  • María Domínguez Ruiz
  • Concepción Villalón Villarroel
  • Eva María García Galloway
  • Patricia Fernández San José
  • Lucía Soletto Esteban
  • Irene Garcia Vaquero
  • Natalia Sannikova
  • Sandra Pérez Rial
  • Marta Pacio Mínguez
  • Patricia Rodríguez Solana
  • Elena Rodríguez de Tiedra
  • Irene Vázquez Domínguez
  • Maria del Pilar Lopez Nieva
Imagen equipo

Group leaders

Miguel Ángel Moreno Pelayo

Matías Morín Rodríguez

mmorenop(ELIMINAR)@salud.madrid.org

Principal Investigator

  • Francisco Javier del Castillo Fernández del Pino
  • Ignacio del Castillo Fernández del Pino

Collaborating Staff

  • Yolanda Martín Santo Domingo
  • Ana María Valero Rubio
  • Manuela Villamar López
  • Verónica Barca Tierno
  • María Domínguez Ruiz
  • Concepción Villalón Villarroel
  • Eva María García Galloway
  • Patricia Fernández San José
  • Lucía Soletto Esteban
  • Irene Garcia Vaquero
  • Natalia Sannikova
  • Sandra Pérez Rial
  • Marta Pacio Mínguez
  • Patricia Rodríguez Solana
  • Elena Rodríguez de Tiedra
  • Irene Vázquez Domínguez
  • Maria del Pilar Lopez Nieva

Strategic objectives

  • Identification of new genes associated with inherited pathologies in hearing loss, anterior segment eye diseases, lysosomal storage diseases, autoinflammatory syndromes, and other rare diseases.
  • Performance of functional assays and generation of cellular and murine models for the study of associated pathogenesis mechanisms.
  • Generation of iPSC-derived cell models from patients (and controls) to identify disease biomarkers.
  • Development, validation, and commercialization of diagnostic tools based on next-generation sequencing and microarrays. Design of clinical guidelines for the group of rare diseases under investigation.
  • Collaborations with companies for the development of advanced therapies.

Research lines

  • Spinal muscular atrophy.
  • Genetic basis of tuberous sclerosis.
  • Genetic and molecular basis of Chiari malformation.
  • Hereditary basis of glaucoma and anterior segment eye pathology.
  • Hereditary retinal dystrophies.
  • Hereditary hearing loss (syndromic and non-syndromic).
  • Lysosomal storage diseases.
  • Autoinflammatory syndromes.
  • Primary immunodeficiencies associated with the TCR/CD3 complex and DNA repair defects.
  • MicroRNA cure: modulation of microRNAs to eliminate latency reservoirs in HIV-infected patients.
  • Neurofibromatosis type 1 and 2, and neuro-cardiofacial-cutaneous syndromes.

Location

Ramón y Cajal University Hospital

Genetics Department
Outpatient Clinic Building, Ground Floor

Keywords

Rare diseases, genetically based pathology, massive sequencing, CGH microarrays, functional assays, transgenic mice, genomics